Assembly Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-21.4M | $-21.4M | $3.2K | $2.8M |
| FY2013 | $-17.8M | $-17.8M | $6.5K | $1.7M |
| FY2014 | $-15.0M | $-15.1M | $150.0K | $10.6M |
| FY2015 | $-18.7M | $-18.8M | $58.3K | $7.9M |
| FY2016 | $-34.9M | $-35.0M | $147.0K | $5.0M |
| FY2017 | $1.9M | $995.0K | $865.0K | $8.6M |
| FY2018 | $-65.0M | $-65.3M | $340.0K | $28.5M |
| FY2019 | $-84.1M | $-85.6M | $1.6M | $20.6M |
| FY2020 | $-63.0M | $-63.4M | $470.0K | $21.9M |
| FY2021 | $-93.4M | $-96.5M | $3.1M | $5.2M |